Company Overview and News
With the recent market volatility, investors are looking for a safe bet. While we all know that volatility can put pressure on stocks everywhere, we also know that those stocks with solid underlying earnings have a great chance of weathering the storm. In fact, periods of market volatility provide fantastic buying opportunities for stocks like this. By leaning on the Zacks Rank, you can uncover stocks with earnings estimates moving in a positive direction.
Chicago, IL – April 10, 2018 – Zacks Equity Research highlights Stoneridge (SRI - Free Report) as the Bull of the Day and Kimco Realty Corp. (KIM - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Boeing Company (BA - Free Report) .
U.S. manufacturing sector is witnessing resurgence under the Trump administration, shrugging off its long phase of weak productivity and sluggish growth. In fact, U.S. manufacturers are increasing capital spending and hiring on the back of massive tax overhaul, deregulatory measures, strong domestic & global economy, weak dollar and robust business sentiment. Under Trump’s presidency, manufacturing sector is observing strong business spending at factories for expensive durable items such as machinery and vehicles.
Chicago, IL – April 5, 2018 - Stocks in this week’s article include: Stoneridge, Inc. (SRI - Free Report) , FGL Holdings (FG - Free Report) , Lindblad Expeditions Holdings, Inc. (LIND - Free Report) , Endocyte, Inc. (ECYT - Free Report) and Knoll, Inc. (KNL - Free Report) .
New analyst coverage provides extensive data on stocks for investors. Analysts are privy to vital information which is crucial for investment decisions. Lack of information creates chances of misinterpretation of stocks (over- or under-valued). Coverage initiation on a stock by analyst(s) usually portrays higher investor inclination. Investors, on their part, often assume that there is something special in a stock to attract analysts to cover it.
On Apr 2, the Institute for Supply Management (ISM) reported its manufacturing index for the month of March. Despite a decline compared with the previous month, the manufacturing sector as a whole remains robust supported by a healthy domestic economy and strong global markets. Also, the U.S. economy is currently in good shape. Notably, the demand for U.S. products remains robust globally. Moreover, worldwide demand for manufacturing products is on the rise.
Thanks to a spate of negative news from some of the key companies in the space, the technology sector is stuck in a vicious web of trading, pushing the large-capitalization technology and internet stocks into a correction zone. This is especially true, as NYSE FANG+ index, which tracks the 10 biggest and most active tech stocks in the world, is down 15.4% from its latest Mar 12 peak. The initial panic was triggered on Mar 19 following Facebook’s (FB - Free Report) data scandal that raised chances of more regulation in the industry.
After witnessing exponential rise throughout 2017, U.S. stock markets have entered into correction territory in the first quarter of 2018. Market volatility reared its ugly face in February due to high inflationary expectations that aggravated in March primarily due to President Trump’s tariff policies and the tech stock plunge, which occurred due to certain company-specific issues. However, strong economic fundamentals of the United States suggest that the recent volatility may be transitory and that markets will continue their uptrend.
Chicago, IL – March 27, 2018 - Stocks in this week’s article include: Pioneer Natural Resources Company (PXD - Free Report) , Centene Corporation (CNC - Free Report) , Mammoth Energy Services, Inc. (TUSK - Free Report) , Stoneridge, Inc. (SRI - Free Report) and FTI Consulting, Inc. (FCN - Free Report) .
Last week, U.S. equities suffered their gravest losses in more than two years. Fears of an impending trade war between the United States and China crippled markets, with the Dow suffering its worst week weekly loss since January 2016. These losses underscore the challenges faced by large-cap stocks in recent times, a trend that is likely to continue.
Earnings growth and valuation multiples are indeed important for investors to determine a stock's ability to offer considerable returns. But these are also essential in determining whether a stock’s price performance is better than its peers or the industry average.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET